The Big Bang Theory actor Mayim Bialik has spoken about her ‘GPL-1 nightmare’ after experiencing weeks of side effects following a single dose. But how typical is that kind of reaction?
Bialik, widely recognised for her role as Amy Fowler in The Big Bang Theory, said she began taking the medication after medical professionals suggested it could potentially benefit her autoimmune condition, as this class of drugs has shown promise in reducing systemic inflammation.
However, she stopped the treatment soon after starting it, saying she developed severe symptoms including ‘explosive, uncontrollable diarrhea, violent sulfur burps and sneezing attacks every time she tried to eat or drink’. Bialik also reported intense bloating, flu-like illness, and difficulty even keeping down small amounts of water.
GLP-1 medications, including Ozempic and Mounjaro, are primarily prescribed for people with type 2 diabetes to support blood sugar control, though they are also widely known for their use in weight management.
Dr Suzanne Wylie, GP and medical adviser for IQdoctor, says: “It is important to stress that while stories such as Mayim Bialik’s understandably attract attention, her experience appears to represent a particularly severe reaction rather than what most people should expect after their first GLP-1 injection.”
According to Dr Wylie, an initial dose of a GLP-1 medication such as semaglutide or tirzepatide is generally more likely to trigger ‘mild to moderate digestive symptoms rather than the extreme reaction described by Bialik.’ Patients are usually started on a lower dose so the body can adjust and the chances of unpleasant side effects are reduced.
“The most common effects during the first few days are nausea, a feeling of fullness after eating small amounts, reduced appetite, occasional acid reflux, bloating, constipation or diarrhoea,” she states.
Dr Wylie explains that nausea in the first 24 to 72 hours after an injection is not necessarily a cause for alarm, as it ‘often improves as the body becomes accustomed to the medication over the following weeks.’
In clinical practice, symptoms such as nausea, mild diarrhoea or constipation often ease without medical treatment, particularly when patients eat smaller portions, stay hydrated, and avoid rich, greasy or heavy meals.
Dr Wylie also notes that many people ‘notice very little’ after their first injection, aside from a reduced appetite. Some patients may also find that high-fat or very rich foods become more difficult to tolerate.
The main point, she says, is that while the first dose can ‘be associated with digestive upset’, most patients do not experience symptoms as severe as those described by Bialik.
“For the average patient, the first week is more likely to involve mild nausea, feeling fuller sooner than expected and a noticeable reduction in appetite, with symptoms gradually improving as treatment continues and doses are increased in a controlled manner,” she added.
Anyone who develops severe or long-lasting symptoms, or signs they may be becoming dehydrated, should contact a healthcare professional. Warning signs include ‘repeated vomiting, inability to keep fluids down, severe abdominal pain, signs of dehydration such as dizziness or reduced urination, or ongoing diarrhoea lasting several days’.